Ciprofloxacin therapy for Mediterranean spotted fever.
AUTOR(ES)
Raoult, D
RESUMO
We report the treatment of five patients with Mediterranean spotted fever with the antimicrobial agent ciprofloxacin. The treatment was administered intravenously for 2 days and then perorally for 8 days. All five patients were cured. These preliminary data seem to correlate with the in vitro activity of ciprofloxacin against Rickettsia conorii.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176489Documentos Relacionados
- Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever.
- Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever.
- Deleterious effect of trimethoprim-sulfamethoxazole in Mediterranean spotted fever.
- Comparison of Western immunoblotting and microimmunofluorescence for diagnosis of Mediterranean spotted fever.
- Line blot and western blot immunoassays for diagnosis of Mediterranean spotted fever.
